OrbiMed Israel GP Ltd. Insider Profile
4 Followers
OrbiMed Israel GP Ltd., Ten Percent Owner at Chemomab Therapeutics, holds 2.24M shares in Chemomab Therapeutics (Ticker: CMMB), holds 8.60M shares in 9 Meters Biopharma (Ticker: NMTRQ), holds 73.65K shares in Eledon Pharmaceuticals (Ticker: ELDN). Most recently, OrbiMed Israel GP Ltd. Sold ― shares of Chemomab Therapeutics on Jan 05, 2023 for an estimated value of $1.21M.
OrbiMed Israel GP Ltd.'s Trading History
You May Also Like
OrbiMed Israel GP Ltd. insider profile FAQ
What is the percentage of profitable transactions made by OrbiMed Israel GP Ltd.?
The percentage of profitable transactions made by OrbiMed Israel GP Ltd. is 80%.
What is the average return per transaction made by OrbiMed Israel GP Ltd.?
The average return per transaction made by OrbiMed Israel GP Ltd. is 33.40%.
What stocks does OrbiMed Israel GP Ltd. hold?
OrbiMed Israel GP Ltd. holds: CMMB, NMTRQ, ELDN stocks.
What was OrbiMed Israel GP Ltd.’s latest transaction?
OrbiMed Israel GP Ltd.’s latest transaction was an Informative Sell of $1.21M.
What was OrbiMed Israel GP Ltd.'s most profitable transaction?
OrbiMed Israel GP Ltd.’s most profitable transaction was an Informative Sell of ELDN stock on December 4, 2020. The return on the trade was 81.80%.
What is OrbiMed Israel GP Ltd.'s role in Chemomab Therapeutics?
OrbiMed Israel GP Ltd.'s role in Chemomab Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
